Isotretinoin, depression and suicide: A review of the evidence

British Journal of General Practice

Volumn 55, Issue 511, 2005, Pages 134-138

  Magin, Parker ^a   Pond, Dimity ^a   Smith, Wayne ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Acne vulgaris; Depression; Isotretinoin; Suicide

Indexed keywords

ANTIDEPRESSANT AGENT; ISOTRETINOIN;

ACNE VULGARIS; ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG SURVEILLANCE PROGRAM; EMBASE; GENERAL PRACTITIONER; HUMAN; INFORMED CONSENT; MEDICAL INFORMATION SYSTEM; MEDLINE; PRESCRIPTION; RISK ASSESSMENT; SELF REPORT; SUICIDAL BEHAVIOR;

ACNE VULGARIS; DEPRESSIVE DISORDER; DERMATOLOGIC AGENTS; HUMANS; ISOTRETINOIN; SUICIDE;

EID: 13844266681     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatological conditions in children and adolescents. J Am Acad Dermatol 2003; 49: 171-182.
2. Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol 2001; 45(5): S150-S157.
3. Lowenstein EJ. Isotretinoin made S.M.A.R.T and simple. Cutis 2002; 70(2): 115-120.
4. Hanson N, Leachman S. Safety issues in isotretinoin therapy. Semin Cutan Med Surg 2001; 20(3): 166-183.
5. Josefson D. Acne drug is linked to severe depression. BMJ 1998; 316(7133): 723.
6. Lamberg L. Acne drug depression warnings highlight need for expert care. JAMA 1998; 279(14): 1057.
7. Wysowski D, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001; 45: 515-519.
8. Schwetz BA. New measures to manage risks associated with accutane. JAMA 2001; 285(5): 1146.
9. Ault A. Isotretinoin use may be linked with depression. Lancet 1998; 351(9104): 730.
10. Hazen PG, Carney JF, Walker AE, Stewart JJ. Depression - a side effect of 13-cis-retinoic acid therapy. J Am Acad Dermatol 1983; 9(2): 278-279.
11. Meyskens FL. Short clinical reports. J Am Acad Dermatol 1982; 6(4[2]): 732.
12. Scheinman PL, Peck GL, Rubinow DR, et al. Acute depression from isotretinoin [comment]. J Am Acad Dermatol 1990; 22(6 Pt 1): 1112-1114.
13. Gatti S, Serri F. Acute depression from isotretinoin [comment]. J Am Acad Dermatol 1991; 25(1 Pt 1):132.
14. Byrne A, Hnatko G. Depression associated with isotretinoin therapy. Can J Psychiatry 1995; 40(9): 567.
15. Lindemayr H. Isotretinoin intoxication in attempted suicide. Acta Derm Venereol 1986; 66(5): 452-453.
16. James M. Isotretinoin for severe acne [comment]. Lancet 1996; 347(9017): 1749-1750.
17. Ng CH, Tam MM, Hook SJ. Acne, isotretinoin treatment and acute depression. World J Biol Psychiatry 2001; 2(3): 159-161.
18. Byrne A, Costello M, Greene E, Zibin T. Isotretinoin therapy and depression - Evidence for an association. Ir J Psychol Med 1998; 15(2): 58-60.
19. Duke EE, Guenther L. Psychiatric reactions to te retinoids. Canadian Journal of Dermatology 1993; 5(4): 467.
20. Wysowski D, Pitts M, Beitz J. Depression and suicide in patients treated with isotretinoin. New Engl J Med 2001; 344(6 : 460-461.
21. Wray CM. Isotretinoin: depression. Canadian Adverse Drug Reaction Newsletter 1999; 9(1): 1.
22. Wooltorton E. Accutane (isotretinoin) and psychiatric adverse effects. CMAJ 2003; 168(1): 66.
23. Medicines Control Agency. In focus: isotretinoin. Current Problems in Pharmacovigilence 1998; 24: 2.
24. Chu A, Cunliffe WJ. The inter-relationship between isotretinoin/acne and depression. J Eur Acad Dermatol Venereol 1999; 12(3): 263.
25. Adverse Drug Reactions Advisory Committee. Depression and isotretinoin. Australian Adverse Drug Reaction Bulletin 1998; 17(3): 11.
26. Kovacs SO, Mallory SB. Mood changes associated with isotretinoin and substance abuse. Pediatr Dermatol 1996; 13(4 : 350.
27. Jick S, Kremers H, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide and attempted suicide. Arch Dermatol 2000; 136(10): 1231.
28. Wysowski D, Beitz J. Methodological limitations of the study 'isotretinoin use and risk of depression psychotic symptoms, suicide and attempted suicide'. Arch Dermatol 2001; 137(8): 1102.
29. Hersom K, Neary MP, Levaux HP, Klaskala W, Strauss JS. Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis. J Am Acad Dermatol 2003; 49(3): 424-32.
30. Hull PR, Demkiw-Bartel C. Isotretinoin use in acne: prospective evaluation of adverse events. J Cutan Med Surg 2000; 4(2): 66-70
31. Bruno NP, Beacham BE, Burnett JW. Adverse effects of isotretinoin therapy. Cutis 1984; 33(5): 484-486, 489.
32. Layton A, Knaggs H, Taylor J, Cunliffe WJ. Isotretinoin for acne vulgaris - ten years later: a safe and successful treatment. Br J Dermatol 1993; 129: 292-296.
33. Goulden V, Layton AM, Cunliffe WJ. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol 1994; 131(3): 360-363.
34. McElwee NE, Schumacher MC, Johnson SC, et al. An observational study of isotretinoin recipients treated for acne in a health maintenance organization. Arch Dermatol 1991; 127(3 : 341-346.
35. McLane J. Analysis of common side effects of isotretinoin. J Am Acad Dermatol 2001; 45(5): S188-S194.
36. Strauss JS, Leyden JJ, Lucky AW, et al. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin [comment]. J Am Acad Dermatol 2001; 45(2): 196-207.
37. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17(1): 25-32.
38. Schulpis K, Georgala S, Papakonstantinou ED, Michas T. Psychological and sympatho-adrenal status in patients with cystic acne. J Eur Acad Dermatol Venereol 1999; 13(1): 24-27.
39. McCaffery P, Drager UC. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc Natl Acad Sci U S A 1994; 91(16): 7772-7776.
40. 2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proc Natl Acad Sci USA 1997; 94(26): 14349-14354.
41. Henderson CA, Highet AS. Depression induced by etretinate. BMJ 1989; 298(6678): 964.
42. Silverman AK, Ellis CN, Voorhees JJ. Hypervitaminosis A syndrome: a paradigm of retinoid side effects. J Am Acad Dermatol 1987; 16(5 Pt 1): 1027-1039.
43. Gupta MA, Gupta AK. Isotretinoin use and reports of sustained dreaming. Br J Dermatol 2001; 144(4): 919-920.
44. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51(1): 8-19.
45. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) [comment]. JAMA 2003; 289(23): 3095-3105.
46. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 1998; 7(1): 3-14.
47. Henderson S, Andrews G, Hall W. Australia's mental health: an overview of the general population survey. Aust N Z J Psychiatry 2000; 34(2): 197-205.
48. Anonymous. From the Centers for Disease Control and Prevention. Regional variations in suicide rates - United States, 1990-1994. JAMA 1997; 278(12): 974-975.
49. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry 1999; 56(7): 617-626.
50. Lewinsohn PM, Rohde P, Seeley JR. Psychosocial risk factors for future adolescent suicide attempts. J Consult Clin Psychol 1994; 62(2): 297-305.
51. Wichstrom L. Predictors of adolescent suicide attempts: a nationally representative longitudinal study of Norwegian adolescents. J Am Acad Child Adolesc Psychiatry 2000; 39(5): 603-610.
52. Jacobs D, Deutsch N, Brewer M. Suicide, depression, and isotretinoin: is there a link? J Am Acad Dermatol 2001; 45: S168-S175.
53. Patton GC, Coffey C, Posterino M, et al. Adolescent depressive disorder: a population-based study of ICD-10 symptoms. Aust N Z J Psychiatry 2000; 34(5): 741-747.
54. Finlay SE. Physical diseases in university students. BMJ 1976; 2(6047): 1312-1314.
55. Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140(4): 672-676.
56. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139(5): 846-850.
57. Polenghi MM, Zizak S, Molinari E. Emotions and acne. Dermatology and Psychosomatics 2002; 3: 20-25.
58. Koo J. The psychosocial impact of acne: patients' perceptions. J Am Acad Dermatol 1995; 32(5 Pt 3): S26-S30.
59. Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140(2): 273-282.
60. Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol 1997; 137(2): 246-250.
61. Wu SF, Kinder BN, Trunnell TN, Fulton JE. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J Am Acad Dermatol 1988; 18(2 Pt 1): 325-333.
62. Grahame V, Dick DC, Morton CM, et al. The psychological correlates of treatment efficacy in acne. Dermatology and Psychosomatics 2002; 3: 119-125.
63. Aktan S, Ozmen E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol 2000; 39(5): 354-357.
64. Smithard A, Glazebrook C, Williams HC. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol 2001; 145(2): 274-279.
65. Pearl A, Arroll B, Lello J, Birchall NM. The impact of acne: a study of adolescents' attitudes, perception and knowledge. N Z Med J 1998; 111(1070): 269-71.
66. Krowchuk DP, Stancin T, Keskinen R, et al. The psychosocial effects of acne on adolescents. Pediatr Dermatol 1991; 8(4): 332-338.
67. Cooper AJ, Australian Roaccutane Advisory B. Treatment of acne with isotretinoin: recommendations based on Australian experience. Australas J Dermatol 2003; 44(2): 97-105.
68. Writing Group for Therapeutics Guidelines. Dermatology. Therapeutics Guidelines: Dermatology. Melbourne: Therapeutics Guidelines Limited, 1999.
69. Van Durme DJ. Family physicians and accutane [comment]. Am Fam Physician 2000; 62(8): 1772, 1774, 1777.
70. Weinberg JM. Scars: the battle over isotretinoin. Cutis 2001; 68(1): 18.
71. Duenwald M. Debate on acne drug's safety persists over two decades. The New York Times 2002; Jan 22: Sect. 7.
72. Millard L. Suicide and the skin. Clin Exp Dermatol 2001; 26(2): 211.
73. Bower P, Rowland N, Mellor C, Heywood P, Godfrey C, Hardy R. Effectiveness and cost effectiveness of counselling in primary care. Cochrane Collaboration. The Cochrane Library, Issue 4. Chichester: John Wiley & Sons, 2004.
74. Hickie IB. An approach to managing depression in general practice. Med J Aust 2OOO; 173(2): 106-110.